Stifel Financial’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-17,064
Closed -$97.4K 3372
2024
Q2
$97.4K Sell
17,064
-13,204
-44% -$75.4K ﹤0.01% 3217
2024
Q1
$152K Sell
30,268
-324,455
-91% -$1.63M ﹤0.01% 3133
2023
Q4
$3.19M Sell
354,723
-391
-0.1% -$3.52K ﹤0.01% 1359
2023
Q3
$2.76M Sell
355,114
-10,907
-3% -$84.7K ﹤0.01% 1381
2023
Q2
$3.54M Buy
366,021
+13,975
+4% +$135K ﹤0.01% 1254
2023
Q1
$3.86M Buy
352,046
+27,463
+8% +$301K 0.01% 1170
2022
Q4
$1.4M Sell
324,583
-643,348
-66% -$2.78M ﹤0.01% 1768
2022
Q3
$7.28M Sell
967,931
-73,606
-7% -$554K 0.01% 764
2022
Q2
$10.5M Sell
1,041,537
-375,416
-26% -$3.77M 0.02% 639
2022
Q1
$17.5M Buy
1,416,953
+682,793
+93% +$8.45M 0.02% 543
2021
Q4
$16.8M Buy
734,160
+54,290
+8% +$1.24M 0.02% 555
2021
Q3
$15M Buy
679,870
+177,655
+35% +$3.93M 0.02% 570
2021
Q2
$6.51M Buy
502,215
+104,206
+26% +$1.35M 0.01% 884
2021
Q1
$5.17M Buy
398,009
+96,943
+32% +$1.26M 0.01% 944
2020
Q4
$4.16M Buy
301,066
+152,638
+103% +$2.11M 0.01% 963
2020
Q3
$2.19M Buy
148,428
+23,110
+18% +$340K ﹤0.01% 1165
2020
Q2
$2.04M Buy
125,318
+63,476
+103% +$1.03M ﹤0.01% 1143
2020
Q1
$894K Buy
61,842
+12,258
+25% +$177K ﹤0.01% 1506
2019
Q4
$1M Buy
49,584
+6,573
+15% +$133K ﹤0.01% 1832
2019
Q3
$231K Buy
43,011
+1,902
+5% +$10.2K ﹤0.01% 2576
2019
Q2
$271K Sell
41,109
-5,411
-12% -$35.7K ﹤0.01% 2550
2019
Q1
$303K Buy
46,520
+3,520
+8% +$22.9K ﹤0.01% 2351
2018
Q4
$295K Sell
43,000
-2,196
-5% -$15.1K ﹤0.01% 2241
2018
Q3
$300K Buy
45,196
+3,378
+8% +$22.4K ﹤0.01% 2360
2018
Q2
$236K Buy
41,818
+20,100
+93% +$113K ﹤0.01% 2446
2018
Q1
$113K Buy
21,718
+10,772
+98% +$56K ﹤0.01% 2555
2017
Q4
$49K Buy
+10,946
New +$49K ﹤0.01% 2591